Stockreport

Cingulate Announces Adjournment of Special Meeting

Cingulate Inc.  (CING) 
PDF KANSAS CITY, Kan., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), (“Cingulate” or the “Company”), a biopharmaceutical company utilizing its proprietar [Read more]